welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
terminated
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)
study id #: NCT00140894
condition: Adenomatous Polyposis Coli
status: terminated
purpose:A study to evaluate rofecoxib in the treatment of rectal, colon, or duodenal adenomas in patients with Familial Adenomatous Polyposis.
intervention:
Drug: MK0966; rofecoxib / Duration of Treatment: 24 weeks
Drug: Comparator: placebo / Duration of Treatment: 24 weeks
study details
study contacts
expertly curated content related to this topic
-
Ureteric Obstruction in Familial Adenomatous Polyposis-Associated Desmoid DiseasePURPOSE : Intra-abdominal desmoid diseas...
-
Successful Radiofrequency Ablation of an Anterior Abdominal Wall Desmoid in Familial Adenomatous PolyposisBACKGROUND : Desmoid tumours are an impo...
-
Our Experience of Treatment of Cribriform Morular Variant of Papillary Thyroid Carcinoma; Difference in Clinicopatho...Cribriform-morular variant (CMV) is a co...
-
Regression of Colonic Adenomas After Treatment with Sulindac in Familial Adenomatous Polyposis: A Case with a 2-Year...Familial adenomatous polyposis (FAP) is ...
-
Rare Coincidence of Familial Adenomatous Polyposis and a Retroperitoneal Fibromyxoid Sarcoma: Report of a CasePURPOSE : Familial adenomatous polyposis...
-
Familial Adenomatous Polyposis – Genetics Home ReferenceFamilial Adenomatous Polyposis (FAP) is ...
-
Primary and Secondary Restorative Proctocolectomy for Familial Adenomatous Polyposis: Complications and Long-Term Bo...AIM : The aim of the study was to evalua...